Evan Ekman, MD
Orthopaedic Surgery · Aiken, SCNPI 1467400119
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $38,305 of the $41,650 with a category attached, or 92.0%. 8 manufacturers reported payments, led by Lilly USA, LLC at 48.0% of the total. Reporting peaked in 2020 at $21,417 and has fallen 66.1% since, to $7,250 in 2021. Among orthopaedic surgery clinicians in SC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 30 payments — averaging $1388.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$20K
- Pfizer$9K
- Vertex$6K
- Eli Lilly$5K
- Acelrx Pharmaceuticals, Inc.$2K
- Stryker$20
- plus $31 from 2 others
Across 6 payments — averaging $1086.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$7K
What the payments were for
- Consulting fees$38,30592%
- Speaking & faculty fees$9302%
- Travel & lodging$2,0355%
- Food & beverage$3791%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 16 | $20,000 |
| Pfizer | 6 | $9,159 |
| Vertex | 2 | $5,625 |
| Eli Lilly | 1 | $4,800 |
| Acelrx Pharmaceuticals, Inc. | 2 | $2,015 |
| Stryker | 1 | $20 |
| Johnson & Johnson | 1 | $20 |
| Dynasplint Systems Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DSUVIA$2,000
How this compares
$41,650 in reported general payments places this provider in the 90th percentile of 325 orthopaedic surgery providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 263 | $5,120 |
| Diclofenac Sodium | 253 | $2,696 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 88 | $581 |
| Gabapentin | 34 | $567 |
| Cephalexin | 39 | $339 |
| Ibuprofen | 29 | $264 |
| Mupirocin | 26 | $201 |
| Meloxicam | 13 | $75 |
| Diazepam | 16 | $13 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Aiken
- Jacob GoodrichAiken$43K
- William SmithColumbia$7.7M
- Richard FrischMt Pleasant$1M
- Brent PonceCharleston$874K
- Chi LimSpartanburg$320K
- Todd LansfordNorth Charleston$286K
- Nicholas GrimaldiColumbia$203K
- Richard MarksWest Columbia$176K
- James LogingClinton$118K
- Justin SmithRock Hill$102K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.